These UK-led efforts come after the US pulled foreign research aid to focus on its domestic health agenda.

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

Last week the Regulation on Clinical Trials (“CTR”) finally became effective in the European Union (“EU”) and replaced the prior Clinical Trials Directive 2001/20 (“CTD”). The CTR was adopted in 2014 ...

Explore the latest NHS funding announcement of nearly £50 million to enhance research capabilities across England ...

The majority of people in the UK (68%) would consider taking part in a clinical trial, it has been revealed today (19 May), while half of Brits would also be willing to take part in an early phase ...

One of the country's first nurses dedicated to dementia research has been appointed in Sheffield to help build on knowledge ...

The government has appointed Lord James O'Shaughnessy, Senior Partner at consultancy firm Newmarket Strategy, Board Member of Health Data Research UK (HDR UK), and former Health Minister, to conduct ...

The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...

Artificial intelligence (AI) is revolutionising clinical trials, offering ways to improve the consent process, but concerns regarding the complete reliability of the technology for sensitive tasks ...